---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-009661"
form_type: "8-K"
ticker: "PMI"
cik: "0002030617"
company_name: "Picard Medical, Inc."
filed_at: "2025-12-03T23:59:59+00:00"
generated_at: "2026-05-16T15:30:54.493138+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Picard Medical CEO to present Emperor TAH data at CSI Focus D-HF in Frankfurt

## Summary
- CEO Patrick NJ Schnegelsberg presenting on December 6, 2025 at 13:00 CET in the 'Durable Mechanical Circulatory Support' session.
- Emperor Total Artificial Heart (TAH) is a fully implantable device; Picard's subsidiary SynCardia makes the first FDA/Health Canada-approved total artificial heart.
- Conference runs December 5-6, 2025 in Frankfurt, Germany; no new financial or operational guidance disclosed in the release.

## SEC filing metadata
- accession: 0001829126-25-009661
- form_type: 8-K
- ticker: PMI
- cik: 0002030617
- company_name: Picard Medical, Inc.
- filed_at: 2025-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030617/000182912625009661/0001829126-25-009661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030617/000182912625009661/picardmedical_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-009661
- JSON: https://secwatch.observer/filing/0001829126-25-009661.json
- Plain text: https://secwatch.observer/filing/0001829126-25-009661.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.